Overview

A Bioequivalence Study of Sildenafil Citrate Orally-Disintegrating Film Dosage Form

Status:
Withdrawn
Trial end date:
2021-04-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the bioequivalence of Sildenafil ODF 50 mg to Viagra® tablet 50 mg under fasted conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Citric Acid
Sildenafil Citrate
Sodium Citrate